Suppr超能文献

甲胎蛋白(AFP)与“七项标准”相结合可能是中国肝硬化肝癌患者肝移植的更好策略。

The Combination of AFP and "Up-To-Seven" Criteria May Be a Better Strategy for Liver Transplantation in Chinese Cirrhotic HCC Patients.

作者信息

Zhang Da-Li, Feng Dan-Ni, He Xi, Zhang Xiao-Feng, Li Li-Xin, Li Zhi-Jie, Niu Xiao-Feng, Zhuang Yun-Long, Liu Zhen-Wen, Gao Xu-Dong, Wang Hong-Bo

机构信息

Department of Hepatology, The Fifth Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.

出版信息

Front Oncol. 2022 Jul 12;12:959151. doi: 10.3389/fonc.2022.959151. eCollection 2022.

Abstract

BACKGROUND

Orthotopic liver transplantation (OLT) is a life-saving option for patients with hepatocellular carcinoma (HCC), but the expanded OLT criteria remain controversial.

OBJECTIVE

The study aimed to explore whether expanded OLT criteria can be applied to Chinese cirrhotic patients with HCC.

METHODS

This retrospective study analyzed risk factors for HCC recurrence and death and compared patients' tumor characteristics and outcomes in groups of Milan, "Up-to-seven," and Hangzhou criteria, and groups between met and unmet the combinative criteria of "Up-to-seven" and AFP of < 1000 ng/mL.

RESULTS

Among 153 patients who underwent OLT for HCC from January 2015 to February 2019 in 4 years of follow-up, 20 (13.1%) patients had HCC recurrence, and 11 (7.2%) had HCC-related death. Multivariate Cox regression analysis showed that preoperative alpha-fetoprotein (AFP) of > 1000 ng/mL (hazard ratio [HR]: 10.05, 95% confidence interval [CI]: 2.45-41.13, P = 0.001) was an independent risk factor for HCC recurrence and HCC-related death (HR: 6.63, 95%CI: 1.31-33.52, P = 0.022). Patients who did not meet Milan criteria but satisfied the "Up-to-seven" criteria had no differences in overall survival (OS) (P = 0.69) and disease-free survival (DFS) (P = 0.35) than patients who met the Milan criteria. The combination of "Up-to-seven" criteria and AFP of < 1000 ng/mL differed significantly (HR: 18.9; 95% CI: 4.0-89.2; P < 0.001). Patients with HCC who met the "Up-to-seven" criteria and AFP of < 1000 ng/mL (n = 121) had excellent survival with 4-year OS of 91.6% (P < 0.001) and DFS of 90.8% (P < 0.001), which is significantly better compared to the other group (n = 32) (OS of 67.5% and DFS of 46.5%) and patients who met the Milan criteria (n = 108, OS of 89.8%, DFS of 89.6%), allowing 28.9% (13/45) of patients who did not meet the Milan criteria to benefit from OLT.

CONCLUSION

Chinese cirrhotic patients with HCC who met the combinative criteria of "Up-to-seven" and AFP of < 1000 ng/mL had better survival than those who met the Milan criteria, and these combinative criteria benefited more patients and may become a better option for OLT.

摘要

背景

原位肝移植(OLT)是肝细胞癌(HCC)患者的一种挽救生命的选择,但扩大的OLT标准仍存在争议。

目的

本研究旨在探讨扩大的OLT标准是否可应用于中国肝硬化HCC患者。

方法

本回顾性研究分析了HCC复发和死亡的危险因素,并比较了米兰标准组、“七标准”组和杭州标准组以及符合和不符合“七标准”与甲胎蛋白(AFP)<1000 ng/mL联合标准的患者的肿瘤特征和结局。

结果

在2015年1月至2019年2月因HCC接受OLT的153例患者中,4年随访期间,20例(13.1%)患者出现HCC复发,11例(7.2%)患者死于HCC相关原因。多因素Cox回归分析显示,术前甲胎蛋白(AFP)>1000 ng/mL(风险比[HR]:10.05,95%置信区间[CI]:2.45 - 41.13,P = 0.001)是HCC复发和HCC相关死亡的独立危险因素(HR:6.63,95%CI:1.31 - 33.52,P = 0.022)。未符合米兰标准但满足“七标准”的患者与符合米兰标准的患者相比,总生存期(OS)(P = 0.69)和无病生存期(DFS)(P = 0.35)无差异。“七标准”与AFP<1000 ng/mL的联合标准差异显著(HR:18.9;95%CI:4.0 - 89.2;P < 0.001)。符合“七标准”且AFP<1000 ng/mL的HCC患者(n = 121)生存良好,4年OS为91.6%(P < 0.001),DFS为90.8%(P < 0.001),与另一组(n = 32)(OS为67.5%,DFS为46.5%)和符合米兰标准的患者(n = 108,OS为89.8%,DFS为89.6%)相比有显著改善,使28.9%(13/45)未符合米兰标准的患者从OLT中获益。

结论

符合“七标准”与AFP<1000 ng/mL联合标准的中国肝硬化HCC患者比符合米兰标准的患者生存更好,这些联合标准使更多患者受益,可能成为OLT的更好选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aab0/9351723/dd769553dcbc/fonc-12-959151-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验